IMO I think the company will get the share price up in the next couple of months, do the money raise, uplist and announce a merger. I think Jay in his unusual style said that they have several business connections that they work well with and have synergy with Rxmd. This is only my opinion but I think that’s what we may see over the next two months.
The trick is to bring buyers in and get the share price up. How will they do that? That’s the $64,000. Question.
News 
Market Data 
Discover 
AI
